Karyopharm extends noteholder forbearance period to Oct. 22

Karyopharm extended its creditor forbearance period to 11:59 p.m. ET on Oct. 22, 2026. The deadline had been set to expire at 11:59 p.m. ET on Oct. 15, 2026, absent earlier termination. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-421025), on October 14, 2026, and is solely responsible for the information contained therein. (C)